It is concluded that EAM-2201 has the potential to trigger in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, and it is evaluated in pooled human liver microsomes. The computed knowledge are when compared Along with the accessible very first principle calculations and experimental details, https://eam-220110753.bmswiki.com/4822539/eam_2201_fundamentals_explained